Drug repositioning

From WikiMD's Wellness Encyclopedia

Drug repositioning (also known as drug repurposing, drug reprofiling or therapeutic switching) is the process of identifying new uses for approved or investigational drugs that are outside the scope of the original medical indication.

Overview[edit | edit source]

Drug repositioning is a strategy for identifying new uses for drugs that are already on the market, bypassing the time and cost associated with traditional drug discovery. This approach can be particularly beneficial in the treatment of rare or orphan diseases, where the potential market may not be large enough to justify the cost of developing a new drug from scratch.

Process[edit | edit source]

The process of drug repositioning can be divided into two main approaches: serendipitous discovery and systematic screening.

Serendipitous discovery is when a new therapeutic use for a drug is discovered by chance. This often occurs during clinical trials for a different indication, or during post-marketing surveillance when unexpected benefits are reported by patients or healthcare professionals.

Systematic screening involves testing a library of approved drugs against a range of diseases in a high-throughput manner. This can be done in vitro using cell-based assays, or in vivo using animal models of disease.

Examples[edit | edit source]

One of the most famous examples of drug repositioning is the case of sildenafil (Viagra). Originally developed by Pfizer for the treatment of angina and hypertension, it was found during clinical trials to have a notable side effect of inducing erections, and was subsequently repositioned for the treatment of erectile dysfunction.

Another example is thalidomide, which was originally marketed in the 1950s as a sedative and antiemetic for morning sickness, but was withdrawn from the market due to its teratogenic effects. It was later repositioned for the treatment of multiple myeloma and leprosy after its anti-inflammatory and immunomodulatory effects were discovered.

Challenges and opportunities[edit | edit source]

While drug repositioning offers a potentially faster and cheaper route to drug development, it is not without its challenges. These include regulatory issues, intellectual property concerns, and the need for further clinical trials to validate the new indication.

However, the opportunities presented by drug repositioning are significant. By leveraging existing data and knowledge, drug repositioning can reduce the risk, cost and time associated with bringing a new drug to market. Furthermore, it can provide new treatment options for patients, particularly those with rare or orphan diseases for which there are currently limited therapies available.

FlattenedRoundPills.jpg
This article is a stub related to pharmacology. You can help WikiMD by expanding it!


WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD